Skip to main content
. 2014 Sep 22;8:1891–1911. doi: 10.2147/OPTH.S47778

Table 1.

List of therapeutic agents discussed in review

Category Class Subtypes Examples
Corticosteroids Corticosteroids Prednisolone
Methylprednisolone
Iluvien
Ozurdex
Retisert
Second-line agents T-cell inhibitors Calcineurin inhibitor Cyclosporine
Tacrolimus
Voclosporin
mTOR inhibitor Everolimus
Sirolimus
Antimetabolites Purine antagonist
DHFR inhibitor
IMPDH inhibitor
Azathioprine
Methotrexate
Mycophenolate mofetil
Alkylating agents Chlorambucil
Cyclophosphamide
Biologics Anti-TNF Anti-TNFα
Anti-TNFα and β
Adalimumab
Certolizumab
Golimumab
Infliximab
Etanercept
Other biologic agents Anti-CD11a
Anti-CD20
Anti-CD28
Anti-CD52
Anti-IL1
Anti-IL1β
Efalizumab
Rituximab
Abatacept
Alemtuzumab
Anakinra
Canakinumab
Gevokizumab
Anti-IL2
Anti-IL6
Anti-IL17A
Interferons
S1P inhibitor
VEGF inhibitors
Daclizumab
Tocilizumab
Secukinumab
Interferon α/β
Fingolimod
Aflibercept
Bevacizumab
Ranibizumab
Other agents Other IVIG

Abbreviations: CD, cluster of differentiation; DHFR, dihydrofolate reductase; IL, interleukin; IMPDH, inosine monophosphate dehydrogenase; IVIG, intravenous immunoglobulin; mTOR, mammalian target of rapamycin; S1P, sphingosine-1-phosphate; TNF, tumor necrosis factor; VEGF, vascular endothelial growth factor.